<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Exicure, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Exicure, Inc.

    Exicure, Inc. is a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drugs against validated targets. Exicure's proprietary 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of therapeutic oligonucleotides in a wide range of cells and tissues. Exicure's lead programs address oncology, inflammatory diseases and genetic disorders. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      David A. Giljohann
    • FOUNDED
      2009
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Precision BioSciences, Inc.

    Precision BioSciences, Inc.

    Precision BioSciences is dedicated to improving life (DTIL) through its proprietar...

    Precision BioSciences is dedicated to improving...

    Filing Type:    PU
    Capricor Therapeutics, Inc.

    Capricor Therapeutics, Inc.

    Capricor Therapeutics, Inc. (Nasdaq: CAPR) is a clinical-stage biotechnology compa...

    Capricor Therapeutics, Inc. (Nasdaq: CAPR) is a...

    Filing Type:    PU
    MTBC, Inc.

    MTBC, Inc.

    MTBC is a healthcare information technology company that provides a fully integrat...

    MTBC is a healthcare information technology com...

    Filing Type:    PU
    Atossa Genetics Inc.

    Atossa Genetics Inc.

    Seattle-based Atossa Genetics (NASDAQ: ATOS) is a clinical-stage biopharmaceutical...

    Seattle-based Atossa Genetics (NASDAQ: ATOS) is...

    Filing Type:    PU
    Seattle Genetics, Inc.

    Seattle Genetics, Inc.

    Founded 20 years ago, Seattle Genetics was built on a foundation of scientific inn...

    Founded 20 years ago, Seattle Genetics was buil...

    Filing Type:    PU
    Zimmerman BioPharma Holding, Inc.

    Zimmerman BioPharma Holding, Inc.

    ZBP is a biopharmaceutical company that has developed a proprietary technology to ...

    ZBP is a biopharmaceutical company that has dev...

    Fundraising Status:    EC
    Filing Type:    RA
    TrovaGene, Inc.

    TrovaGene, Inc.

    Trovagene is a clinical-stage, oncology therapeutics company, taking a precision m...

    Trovagene is a clinical-stage, oncology therape...

    Filing Type:    PU
    Diffusion Pharmaceuticals Inc.

    Diffusion Pharmaceuticals Inc.

    Diffusion Pharmaceuticals is a clinical stage company focused on improving the eff...

    Diffusion Pharmaceuticals is a clinical stage c...

    Filing Type:    PU
    bluebird bio, Inc.

    bluebird bio, Inc.

    bluebird bio is pioneering gene therapy with purpose. From our Cambridge, Mass., h...

    bluebird bio is pioneering gene therapy with pu...

    Filing Type:    PU
    Viela Bio, Inc.

    Viela Bio, Inc.

    Viela is dedicated to the development and commercialization of novel, life-changin...

    Viela is dedicated to the development and comme...

    Filing Type:    PU
    Equillium, Inc.

    Equillium, Inc.

    Equillium is a biotechnology company leveraging deep understanding of immunobiolog...

    Equillium is a biotechnology company leveraging...

    Filing Type:    PU
    Apellis Pharmaceuticals, Inc.

    Apellis Pharmaceuticals, Inc.

    We are a clinical-stage biopharmaceutical company focused on the development of no...

    We are a clinical-stage biopharmaceutical compa...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.